These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2965848)

  • 1. Suppressive effect of quinolinic acid and hippuric acid on bone marrow erythroid growth and lymphocyte blast formation in uremia.
    Kawashima Y; Sanaka T; Sugino N; Takahashi M; Mizoguchi H
    Adv Exp Med Biol; 1987; 223():69-72. PubMed ID: 2965848
    [No Abstract]   [Full Text] [Related]  

  • 2. [Study on the uremic protein binding inhibitors as uremic toxin: toxic effect on erythroid colony formation, lymphocyte blast formation and renal function].
    Kawashima Y
    Nihon Jinzo Gakkai Shi; 1989 Nov; 31(11):1151-61. PubMed ID: 2533943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of uremic toxins in exacerbating anemia in renal failure.
    Macdougall IC
    Kidney Int Suppl; 2001 Feb; 78():S67-72. PubMed ID: 11168986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocyte response in acute experimental renal failure.
    Slavin RG; Kelly JF; Garrett JJ
    J Immunol; 1970 Jun; 104(6):1424-8. PubMed ID: 5419278
    [No Abstract]   [Full Text] [Related]  

  • 5. Separation of peptidic inhibitor of erythropoiesis in uremia.
    Saito A; Ogawa H; Chung TG; Hotta T
    Adv Exp Med Biol; 1987; 223():111-4. PubMed ID: 3447424
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibitors of erythroid colony-forming cells (CFU-E and BFU-E) in sera of azotemic patients with anemia of renal disease.
    Ohno Y; Rege AB; Fisher JW; Barona J
    J Lab Clin Med; 1978 Dec; 92(6):916-23. PubMed ID: 739170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anemia of chronic renal failure: erythropoiesis and serum inhibitor(s) of erythroid progenitor cells in uremia].
    Urushiyama M; Moriyama Y
    Rinsho Ketsueki; 1985 May; 26(5):668-73. PubMed ID: 4057581
    [No Abstract]   [Full Text] [Related]  

  • 8. Accumulation of quinolinic acid in uremic serum and its removal by hemodialysis.
    Niwa T; Yoshizumi H; Emoto Y; Miyazaki T; Hashimoto N; Takeda N; Tatematsu A; Maeda K
    Clin Chem; 1991 Feb; 37(2):159-61. PubMed ID: 1825184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular mechanism of resistance to erythropoietin.
    Casadevall N
    Nephrol Dial Transplant; 1995; 10 Suppl 6():27-30. PubMed ID: 8524490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of inhibitors of heme synthesis and bone marrow erythroid colony forming cells in the mechanism of anemia of renal insufficiency.
    Fisher JW; Moriyama Y; Rege AB; Tornyos K; Lertora JJ
    Proc Clin Dial Transplant Forum; 1974; (4):141-6. PubMed ID: 4468411
    [No Abstract]   [Full Text] [Related]  

  • 11. Polymeric protein-polyamine conjugates: a new class of uremic toxins affecting erythropoiesis.
    Galli F; Beninati S; Benedetti S; Lentini A; Canestrari F; Tabilio A; Buoncristiani U
    Kidney Int Suppl; 2001 Feb; 78():S73-6. PubMed ID: 11168987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of protein binding inhibitor on cultivated lymphocytes in uremic patients].
    Sanaka T; Kawashima Y; Takahashi F; Takuma T; Ota K; Sugino N
    Nihon Jinzo Gakkai Shi; 1983 Aug; 25(8):1063-9. PubMed ID: 6668745
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of CFU-E colony formation in uremic patients with inflammatory disease: role of IFN-gamma and TNF-alpha.
    Allen DA; Breen C; Yaqoob MM; Macdougall IC
    J Investig Med; 1999 May; 47(5):204-11. PubMed ID: 10361379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The uraemic retention solute para-hydroxy-hippuric acid attenuates apoptosis of polymorphonuclear leukocytes from healthy subjects but not from haemodialysis patients.
    Cohen G; Raupachova J; Wimmer T; Deicher R; Hörl WH
    Nephrol Dial Transplant; 2008 Aug; 23(8):2512-9. PubMed ID: 18319358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hippuric acid as a marker.
    Vanholder R; Schoots A; Cramers C; De Smet R; Van Landschoot N; Wizemann V; Botella J; Ringoir S
    Adv Exp Med Biol; 1987; 223():59-67. PubMed ID: 3447451
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of uremic middle molecules on in vitro stimulated lymphocytes and interleukin-2 production.
    Severini G; Diana L; Di Giovannandrea R; Sagliaschi G
    ASAIO J; 1996; 42(1):64-7. PubMed ID: 8808461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quinolinic acid effects on amino acid release from the rat cerebral cortex in vitro and in vivo.
    Connick JH; Stone TW
    Br J Pharmacol; 1988 Apr; 93(4):868-76. PubMed ID: 2898959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressive effect of human interferons on erythroid colony growth in disorders of erythropoiesis.
    Lutton JD; Levere RD
    J Lab Clin Med; 1980 Aug; 96(2):328-33. PubMed ID: 6156973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on uremic toxins; structure-activity correlation in H-Asp(Gly)-OH.
    Abiko T; Kumikawa M; Dazai S; Takahashi H; Ishizaki M; Sekino H
    Biochem Biophys Res Commun; 1978 May; 82(2):707-15. PubMed ID: 666867
    [No Abstract]   [Full Text] [Related]  

  • 20. Erythropoietic action of dexamethasone on the anemia associated with an experimental chronic renal failure.
    Malgor LA; Barrios L; de Albarenque MV; Verges E; de Markowsky EE; Montiel E; Mussin SM
    Acta Physiol Pharmacol Latinoam; 1987; 37(3):365-76. PubMed ID: 3503475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.